Tungsten oxide nanowires and polyaniline hybrid film-based electrochromic device with multicolor display and enhanced capacitance

Electrochromic devices(ECDs)have exhibited promising applications in the fields of energy-saving intelligent buildings and next-generation displays because of their simple structure,low power consumption,and multicolor displays.W_(18)O_(49)/polyaniline(PANI)hybrid films are prepared and assembled to ECDs.Compared with pure PANI and W_(18)O_(49) films,the hybrid film exhibits superior electrochemical and electrochromic performance,including high optical modulation(70.2%),large areal capacity(79.6 mF/cm^(2)),and good capacitance retention.The excellent electrochemical and electrochromic performance is ascribed to the formation of the donor(PANI)-acceptor(W_(18)O_(49))pair,the porous structure in the nanowires,and the large surface area,which enhance electron delocalization of the W_(18)O_(49)/PANI,improve the ion diffusion rate,and increase the charge storage sites.Furthermore,benefitting from the outstanding optical,electrical,and multifunctional properties,the W_(18)O_(49)/PANI hybrid film-based ECD platform is expected to play an important role in electrochromism and energy storage.

活体肝移植供肝脂肪变性评估研究进展

脂肪变性供肝作为边缘性供肝,已成为扩展供肝来源的重要渠道。因此,肝移植术前评估供肝脂肪变性程度尤为重要。临床判断肝脂肪变性发展程度以肝穿刺活检结果作为依据,但给患者带来一定创伤风险。随着影像学和生物学检测技术的不断发展,超声、CT、MRI、磁共振波谱分析和生物标志物等已被用于评估肝移植供肝脂肪变性程度。本文综述上述临床手段在评估脂肪变性供肝质量方面的研究进展,分析其在临床应用中的优缺点,为临床安全、快速和无创评估脂肪变性供肝提供参考。

circBIRC6 contributes to the development of non-small cell lung cancer via regulating microRNA-217/amyloid beta precursor protein binding protein 2 axis

Background:Circular RNAs(circRNAs)are considered to be important regulators in cancer biology.In this study,we focused on the effect of circRNA baculoviral inhibitor of apoptosis protein(IAP)repeat containing 6(circBIRC6)on non-small cell lung cancer(NSCLC)progression.Methods:The NSCLC and adjacent non-tumor tissues were collected at Shanghai Ninth People's Hospital.Quantitative real-time polymerase chain reaction was conducted for assessing the levels of circBIRC6,amyloid beta precursor protein binding protein 2(APPBP2)messenger RNA(mRNA),baculoviral IAP repeat containing 6 mRNA(BIRC6),and microRNA-217(miR-217).Western blot assay was adopted for measuring the protein levels of APPBP2,E-cadherin,N-cadherin,and vimentin.Colony formation assay,transwell assay,and flow cytometry analysis were utilized for evaluating cell colony formation,metastasis,and apoptosis.Dualluciferase reporter assay and RNA immunoprecipitation assay were carried out to determine the interaction between miR-217 and circBIRC6 and APPBP2 in NSCLC tissues.The murine xenograft model assay was used to investigate the function of circBIRC6 in tumor formation in vivo.Differences were analyzed via Student's t test or one-way analysis of variance.Pearson's correlation coefficient analysis was used to analyze linear correlation.Results:CircBIRC6 was overexpressed in NSCLC tissues and cells.Knockdown of circBIRC6 repressed the colony formation and metastasis and facilitated apoptosis of NSCLC cells in vitro and restrained tumorigenesis in vivo.Mechanically,circBIRC6 functioned as miR-217 sponge to promote APPBP2 expression in NSCLC cells.MiR-217 inhibition rescued circBIRC6 knockdown-mediated effects on NSCLC cell colony formation,metastasis,and apoptosis.Overexpression of miR-217 inhibited the malignant phenotypes of NSCLC cells,while the effects were abrogated by elevating APPBP2.Conclusion:CircBIRC6 aggravated NSCLC cell progression by elevating APPBP2 via sponging miR-217,which might provide a fresh perspective on NSCLC therapy.

Advances in graphene oxide membranes for water treatment

Graphene oxide(GO),a derivative of graphene,is a novel carbon material that has attracted a lot of attention in the field of membrane materials as its ability to achieve layer-by-layer stacking and the formation of nanochannels between the lamellae makes it excellent for selective separation of substances.In this paper,the separation mechanism of the GO membrane is summarized.According to the different separation substances,the separation mechanism of graphene oxide membrane is reviewed from two aspects of metal ions and organic pollutants.Next,the preparation methods of graphene oxide membranes is introduced,such as spin-coating,vacuum filtration,dip-coating,spraying,and layer-by-layer self-assembly,followed by a review on the structural regulation of GO.Finally,this paper concludes with an overview of the potential development prospects and challenges of GO membranes.

Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation:Beijing experience

Background:To evaluate the impact of steatosis and/or idiopathic portal inflammation(IPI)in living donor livers on recipients’clinical outcomes.Methods:We assessed 305 qualified donor liver samples from June 2013 to December 2018.Donors and recipients’clinical characteristics,including follow-up data were retrieved.The graft and overall survival with/without steatosis or portal inflammation were compared by Kaplan-Meier analysis.Results:For living donors,the medium age of was 31.2(28,35.8)years old;liver histopathology showed macrovesicular steatosis:0-5%264/305(86.6%)and 5-30%41/305(13.4%),IPI:no 220/305(72.1%)and mild 85/305(27.9%).For recipients,the medium age was 1.0(0.6,1.5)years old;the median pediatric-end-stage-liver-disease score was 16(5.0,26.0)and medium follow-up time was 32.8(24.8,52.0)months.Biliary atresia(69.5%)was the main indication for liver transplantation(LT).Conclusions:The presence of steatosis and portal inflammation of the donor liver did not impact the clinical outcomes including transaminase or bilirubin normalization,short-/long-term complications and recipients’survival.However,recipients with high pediatric-end-stage-liver-disease score(>16)receiving donor liver with portal inflammation,but not steatosis,had trend negative effect on recipients’survival.In conclusion,donor livers with mild steatosis and portal inflammation were qualified for pediatric living donor LT.However,donor liver with mild portal inflammation would better not be allocated to recipients with high pediatric-end-stage-liver-disease score.This study provided new evidence in pediatric living donor liver allocation.